Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-27

Biosafe coronavirus vaccine vector for the prevention of human infections of the enteric and respiratory tract (BIOSAFE-VACCINE-VECTOR)

Obiettivo

The objective is a comprehensive approach for the treatment and protection against human enteric and respiratory infectious diseases by using a vector based on recently isolated corona virus coda genome that amplifies the gene of interest inducing protection without the production of infectious virus and the development of a transgenic mouse model to test vector efficacy. The vector is produced in packaging cell line that provides an essential component for virus vector replication, missing in the virus genome. Additional bio safety strategies, like the relocation of the genome-packaging signal, will lead to an extremely secure virus vector. The expression system will be applied to the protection against human enteric rotavirus and corona virus causing enteric necrosis in children or respiratory infections in adult.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Invito a presentare proposte

Dati non disponibili

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Contributo UE
Nessun dato
Indirizzo
Campus de la Universidad Autonoma de Madrid
28049 MADRID
Spagna
Costo totale
Nessun dato

Partecipanti (5)